5-135535143-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006161.3(NEUROG1):āc.548C>Gā(p.Ala183Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,608,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006161.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROG1 | NM_006161.3 | c.548C>G | p.Ala183Gly | missense_variant | 1/1 | ENST00000314744.6 | NP_006152.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEUROG1 | ENST00000314744.6 | c.548C>G | p.Ala183Gly | missense_variant | 1/1 | 6 | NM_006161.3 | ENSP00000317580.4 | ||
ENSG00000250167 | ENST00000698884.1 | n.496+48374G>C | intron_variant | |||||||
SLC25A48 | ENST00000698885.1 | n.364+25387G>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000160 AC: 38AN: 237500Hom.: 0 AF XY: 0.000108 AC XY: 14AN XY: 129550
GnomAD4 exome AF: 0.000120 AC: 175AN: 1456822Hom.: 0 Cov.: 31 AF XY: 0.000104 AC XY: 75AN XY: 724384
GnomAD4 genome AF: 0.000158 AC: 24AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.000162 AC XY: 12AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.548C>G (p.A183G) alteration is located in exon 1 (coding exon 1) of the NEUROG1 gene. This alteration results from a C to G substitution at nucleotide position 548, causing the alanine (A) at amino acid position 183 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at